As Americans continue to struggle to afford their medical bills, and some newly insured under the Affordable Care Act find they can’t afford to use the coverage they purchased, finding the “right” health insurance plan is important.
As Americans continue to struggle to afford their medical bills, and some newly insured under the Affordable Care Act find they can’t afford to use the coverage they purchased, finding the “right” health insurance plan is important.
The University of Michigan Center for Value-Based Insurance Design, led by A. Mark Fendrick, MD, director of the center and co-editor-in-chief of The American Journal of Managed Care, has released a new whiteboard video highlighting the benefits of a value-based insurance design (VBID) plan.
In the video, Goldilocks Choose a Health Plan, the titular character tries out a health plan that is “too soft,” which may cover many services, have a broad provider network, and include low cost-sharing, but also encourages wasteful spending and will be subject to the Cadillac tax. She also looks at a plan that is “too hard,” with high deductibles, narrow networks, and few covered services before the deductible and which could worsen health disparities and lead to adverse health outcomes.
The VBID plan ends up being “just right” by lowering cost-sharing for high-value services, discouraging use of services with no proven value, and an affordable price. Watch the full video from the VBID Center.
Recently, CMS announced that it would be holding a 5-year demonstration in 7 states of VBID in Medicare Advantage.
“The 5-year model will look, at the end, to see if lowering cost-sharing for high-value services and providers will meet the triple aim of better quality of care, better patient experience, and lower healthcare costs,” explained Dr Fendrick.
He also outlined that some of the hurdles that need to be overcome with the demonstration are concerns about who will enroll and if people understand and take advantage of the lower cost-sharing.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More